These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31209525)

  • 1. The search of potential inhibitors of the AcrAB-TolC system of multidrug-resistant Escherichia coli: an in silico approach.
    Abdel-Halim H; Al Dajani A; Abdelhalim A; Abdelmalek S
    Appl Microbiol Biotechnol; 2019 Aug; 103(15):6309-6318. PubMed ID: 31209525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli.
    Opperman TJ; Kwasny SM; Kim HS; Nguyen ST; Houseweart C; D'Souza S; Walker GC; Peet NP; Nikaido H; Bowlin TL
    Antimicrob Agents Chemother; 2014; 58(2):722-33. PubMed ID: 24247144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of natural compound inhibitors for multidrug efflux pumps of Escherichia coli and Pseudomonas aeruginosa using in silico high-throughput virtual screening and in vitro validation.
    Aparna V; Dineshkumar K; Mohanalakshmi N; Velmurugan D; Hopper W
    PLoS One; 2014; 9(7):e101840. PubMed ID: 25025665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2019 Garrod Lecture: MDR efflux in Gram-negative bacteria-how understanding resistance led to a new tool for drug discovery.
    Piddock LJV
    J Antimicrob Chemother; 2019 Nov; 74(11):3128-3134. PubMed ID: 31626705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total alkaloids of Sophorea alopecuroides-induced down-regulation of AcrAB-TolC efflux pump reverses susceptibility to ciprofloxacin in clinical multidrug resistant Escherichia coli isolates.
    Zhou X; Jia F; Liu X; Wang Y
    Phytother Res; 2012 Nov; 26(11):1637-43. PubMed ID: 22371352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding site feature description of 2-substituted benzothiazoles as potential AcrAB-TolC efflux pump inhibitors in E. coli.
    Yilmaz S; Altinkanat-Gelmez G; Bolelli K; Guneser-Merdan D; Ufuk Over-Hasdemir M; Aki-Yalcin E; Yalcin I
    SAR QSAR Environ Res; 2015; 26(10):853-71. PubMed ID: 26559566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artesunate enhances the antibacterial effect of {beta}-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC.
    Li B; Yao Q; Pan XC; Wang N; Zhang R; Li J; Ding G; Liu X; Wu C; Ran D; Zheng J; Zhou H
    J Antimicrob Chemother; 2011 Apr; 66(4):769-77. PubMed ID: 21393180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of AcrAB-TolC to multidrug resistance in an Escherichia coli sequence type 131 isolate.
    Schuster S; Vavra M; Schweigger TM; Rossen JWA; Matsumura Y; Kern WV
    Int J Antimicrob Agents; 2017 Sep; 50(3):477-481. PubMed ID: 28689875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of AcrAB-TolC Efflux Pumps on Quinolone Resistance of E. coli ST131.
    Atac N; Kurt-Azap O; Dolapci I; Yesilkaya A; Ergonul O; Gonen M; Can F
    Curr Microbiol; 2018 Dec; 75(12):1661-1666. PubMed ID: 30283991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escherichia coli resistance mechanism AcrAB-TolC efflux pump interactions with commonly used antibiotics: a molecular dynamics study.
    Smith BL; Fernando S; King MD
    Sci Rep; 2024 Feb; 14(1):2742. PubMed ID: 38302495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of multidrug efflux pump inhibitors with a novel chemical scaffold.
    Green AT; Moniruzzaman M; Cooper CJ; Walker JK; Smith JC; Parks JM; Zgurskaya HI
    Biochim Biophys Acta Gen Subj; 2020 Jun; 1864(6):129546. PubMed ID: 32032658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the Role of AcrAB-TolC Efflux Pumps in the Evolution of Antibiotic Resistance Reveals Near-MIC Treatments Facilitate Resistance Acquisition.
    Langevin AM; El Meouche I; Dunlop MJ
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33328350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorinated Beta-diketo Phosphorus Ylides Are Novel Efflux Pump Inhibitors in Bacteria.
    Kincses A; Szabó ÁM; Saijo R; Watanabe G; Kawase M; Molnár J; Spengler G
    In Vivo; 2016 11-12; 30(6):813-817. PubMed ID: 27815466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Efflux Pump Inhibitors: A Promising Approach to Counter Multidrug Resistance in Gram-Negative Pathogens by Targeting AcrB Protein from AcrAB-TolC Multidrug Efflux Pump from
    Alenazy R
    Biology (Basel); 2022 Sep; 11(9):. PubMed ID: 36138807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives.
    Sjuts H; Vargiu AV; Kwasny SM; Nguyen ST; Kim HS; Ding X; Ornik AR; Ruggerone P; Bowlin TL; Nikaido H; Pos KM; Opperman TJ
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3509-14. PubMed ID: 26976576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ structure and assembly of the multidrug efflux pump AcrAB-TolC.
    Shi X; Chen M; Yu Z; Bell JM; Wang H; Forrester I; Villarreal H; Jakana J; Du D; Luisi BF; Ludtke SJ; Wang Z
    Nat Commun; 2019 Jun; 10(1):2635. PubMed ID: 31201302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of
    Chowdhury N; Suhani S; Purkaystha A; Begum MK; Raihan T; Alam MJ; Islam K; Azad AK
    Microbiol Insights; 2019; 12():1178636119889629. PubMed ID: 31839709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efflux pump inhibiting properties of racemic phenothiazine derivatives and their enantiomers on the bacterial AcrAB-TolC system.
    Spengler G; Takács D; Horváth A; Szabó AM; Riedl Z; Hajós G; Molnár J; Burián K
    In Vivo; 2014; 28(6):1071-5. PubMed ID: 25398801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering a CRISPR interference system targeting AcrAB-TolC efflux pump to prevent multidrug resistance development in Escherichia coli.
    Wan X; Li Q; Olsen RH; Meng H; Zhang Z; Wang J; Zheng H; Li L; Shi L
    J Antimicrob Chemother; 2022 Jul; 77(8):2158-2166. PubMed ID: 35642356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of VceC gain-of-function mutants that can function with the AcrAB multiple-drug-resistant efflux pump of Escherichia coli.
    Vediyappan G; Borisova T; Fralick JA
    J Bacteriol; 2006 Jun; 188(11):3757-62. PubMed ID: 16707668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.